Method of reducing reperfusion injury with imidazol-2-thiones
申请人:Merrell Dow Pharmaceuticals Inc.
公开号:US04999365A1
公开(公告)日:1991-03-12
Certain imidazol-2-thiones are reported to reduce reperfusion injury which is the injury which occurs when molecular oxygen is reintroduced into an ischemic tissue. These compounds could be used to prevent much of the damage which occurs to the heart of a heart attack victim.
This invention relates to aroylimidazole-2-ones and their acid and base addition salts as well as their use as cardiotonics in the treatment of cardiac failure.
本发明涉及甲酰基咪唑-2-酮及其酸和碱加成盐,以及它们作为治疗心力衰竭的强心剂的用途。
Use of imidazol-2-thiones for the preparation of a medicament for reducing myocardial stunning
申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0284925A2
公开(公告)日:1988-10-05
Certain imidazol-2-thiones are reported to reduce reperfusion injury which is the injury which occurs when molecular oxygen is reintroduced into an ischemic tissue. These compounds could be to prevent much of the damage which occurs to the heart of a heart attack victim.